The American Thoracic Society (ATS) 2025 International Conference featured a session titled ‘Pediatric Year in Review,’ during which several talks were given by panelists such as Lisa G. Wood, PhD, who pointed to recent data on diet’s association with respiratory health outcomes. Wood, who is known for her research at the Hunter Medical Research Institute … Read more
In a recent case series presented at the American Thoracic Society (ATS) 2025 International Conference in San Francisco, dupilumab (Dupixent) treatment has been shown to be safe and generally well-tolerated in patients with chronic obstructive pulmonary disease (COPD) and elevated eosinophil counts.1 The data, suggesting that dupilumab’s utilization was linked to fewer exacerbations and improvement … Read more
Ahmedabad: The Gujarat Anti-Terrorism Squad (ATS) has arrested 18-year-old Jasim Shahnawaz Ansari from Nadiad who, along with other juvenile accomplices, orchestrated multiple cyberattacks against several Indian government websites, especially amid Operation Sindoor, India’s military response following the Pahalgam terror attack. The Gujarat ATS said the accused, a 12th-grade dropout who gained expertise in various programming … Read more
At the 2025 American Thoracic Society (ATS) International Conference, Arthur L. Reingold, MD, professor of epidemiology at UC Berkeley Public Health and expert in the prevention and control of infectious diseases, spoke with HCPLive on addressing public concerns over immunizations and combatting misinformation on the topic. This interview segment was a part of a larger … Read more
At the American Thoracic Society (ATS) International Conference in San Francisco, a presentation titled ‘Vaccines in the Crosshairs: Facing Contemporary Challenges in Immunization Science’ was given to attendees at the pulmonology conference. One presenter, Grace Lee, MD, MPH—known for her work as a professor of pediatrics at Stanford University School of Medicine—addressed contemporary challenges in … Read more
Vivienne Kahlmann, MD Credit: EurekAlert.org New findings presented at the 2025 American Thoracic Society (ATS) International Conference suggest that methotrexate may be considered an effective alternative treatment to prednisone for pulmonary sarcoidosis.1,2 Although prednisone is widely considered to be the initial therapy for pulmonary sarcoidosis, its implementation is known to be commonly accompanied by different … Read more